NeuroPace (NPCE) Equity Average (2020 - 2026)

NeuroPace's Equity Average history runs 7 years deep, the most recent figure standing at $16.7 million for Q1 2026.

• In Q1 2026, Equity Average rose 3.73% year-over-year to $16.7 million; the TTM figure through Mar 2026 stood at $16.7 million (up 3.73% YoY), while the FY2025 annual figure was $13.5 million, down 5.66% from the prior year.
• Equity Average was $16.7 million for Q1 2026 at NeuroPace, down from $18.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $68.2 million in Q1 2022 to a low of $8.9 million in Q4 2024.
• Historically, Equity Average has averaged $26.3 million across 5 years, with a median of $18.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Equity Average jumped 270.76% in 2022, then plunged 60.97% in 2023.
• A 5-year view of Equity Average shows it stood at $39.1 million in 2022, then slumped by 52.66% to $18.5 million in 2023, then slumped by 51.82% to $8.9 million in 2024, then soared by 110.52% to $18.8 million in 2025, then declined by 10.82% to $16.7 million in 2026.
• The last three Equity Average figures came in at $16.7 million (Q1 2026), $18.8 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.